Park Avenue Securities LLC Acquires 192 Shares of Azenta, Inc. (NASDAQ:AZTA)

Park Avenue Securities LLC grew its holdings in Azenta, Inc. (NASDAQ:AZTA) by 1.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,181 shares of the company’s stock after acquiring an additional 192 shares during the quarter. Park Avenue Securities LLC’s holdings in Azenta were worth $734,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of AZTA. Invesco Ltd. increased its stake in Azenta by 35.4% during the 3rd quarter. Invesco Ltd. now owns 331,012 shares of the company’s stock worth $16,613,000 after purchasing an additional 86,477 shares in the last quarter. LPL Financial LLC raised its holdings in shares of Azenta by 11.7% during the third quarter. LPL Financial LLC now owns 71,472 shares of the company’s stock worth $3,579,000 after acquiring an additional 7,468 shares during the period. Trexquant Investment LP acquired a new position in Azenta in the 3rd quarter worth $860,000. Tower Research Capital LLC TRC increased its holdings in Azenta by 101.9% during the 3rd quarter. Tower Research Capital LLC TRC now owns 6,950 shares of the company’s stock worth $349,000 after purchasing an additional 3,508 shares in the last quarter. Finally, Bank of Nova Scotia bought a new position in Azenta during the 3rd quarter worth about $7,875,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Azenta Stock Down 3.7 %

Shares of Azenta stock opened at $52.10 on Friday. Azenta, Inc. has a 12-month low of $43.43 and a 12-month high of $69.16. The business’s 50 day moving average is $52.78 and its 200-day moving average is $59.23. The stock has a market cap of $2.81 billion, a P/E ratio of -19.23 and a beta of 1.51.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Azenta had a negative net margin of 23.12% and a positive return on equity of 0.81%. The company had revenue of $159.13 million during the quarter, compared to the consensus estimate of $159.89 million. During the same quarter last year, the firm posted ($0.06) EPS. The company’s quarterly revenue was up 7.2% on a year-over-year basis. On average, sell-side analysts expect that Azenta, Inc. will post 0.3 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on AZTA. Jefferies Financial Group assumed coverage on Azenta in a research report on Thursday, April 4th. They set a “hold” rating and a $64.00 price objective for the company. Needham & Company LLC reduced their price target on Azenta from $75.00 to $69.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Finally, Evercore ISI lowered their price objective on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a report on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $68.40.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.